SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-24-032029
Filing Date
2024-02-12
Accepted
2024-02-12 16:06:32
Documents
2
Group Members
ANSBERT GADICKELUKE EVNINMPM ASSET MANAGEMENT INVESTORS BV2018 LLCMPM BIOVENTURES 2018 (B), L.P.MPM BIOVENTURES 2018 GP LLCMPM BIOVENTURES 2018 LLCTODD FOLEY

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d760535dsc13ga.htm SC 13G/A 146847
2 EX-99.A d760535dex99a.htm EX-99.A 12017
  Complete submission text file 0001193125-24-032029.txt   160647
Mailing Address 450 KENDALL STREET CAMBRIDGE MA 02142
Business Address 450 KENDALL STREET CAMBRIDGE MA 02142 617-425-9200
MPM BIOVENTURES 2018, L.P. (Filed by) CIK: 0001729505 (see all company filings)

IRS No.: 823687697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Subject) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91706 | Film No.: 24619902
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)